Mitochondrial DNA copy number is regulated by cellular proliferation: A role for Ras and p66Shc  by Trinei, Mirella et al.
1757 (2006) 624–630
http://www.elsevier.com/locate/bbaBiochimica et Biophysica ActaMitochondrial DNA copy number is regulated by cellular proliferation:
A role for Ras and p66Shc
Mirella Trinei ⁎, Ina Berniakovich, Pier Giuseppe Pelicci, Marco Giorgio
European Institute of Oncology, Via Ripamonti 435 Milan, Italy
Firc Institute for Molecular Oncology, Via Adamello 16 Milan, Italy
Received 30 December 2005; received in revised form 3 May 2006; accepted 15 May 2006
Available online 25 May 2006Abstract
The abundance of mitochondria is regulated by biogenesis and division. These processes are controlled by cellular factors, given that, for
example, mitochondria have to replicate their DNA prior to cell division. However, the mechanisms that allow a synchronization of cell
proliferation with mitochondrial genome replication are still obscure. We report here our investigations on the role of proliferation and the
contribution of Ras and p66Shc in the regulation of mitochondrial DNA copy number. Ras proteins mediate a variety of receptor-transduced
mitogenic signals and appear to play an essential role in the cellular response to growth factors. P66Shc is a genetic determinant of life span in
mammals and has been implicated in the regulation of receptor signaling and various mitochondrial functions. First, we confirmed previous
reports showing that mitochondrial DNA is replicated during a specific phase of the cell cycle (the pre-S phase) and provided novel evidences that
this process is regulated by mitogenic growth factors. Second, we showed that mitochondrial DNA replication is activated following Ras-induced
cellular hyper-proliferation. Finally, we showed that p66Shc expression induces mitochondrial DNA replication, both in vitro and in vivo. We
suggest that mitochondria are target of intracellular signaling pathways leading to proliferation, involving Ras and p66Shc, which might function to
integrate cellular bio-energetic requirements and the inheritance of mitochondrial DNA in a cell cycle-dependent manner.
© 2006 Elsevier B.V. All rights reserved.Keywords: DNA; Ras signaling; p66Shc and aging1. Introduction
1.1. Mitochondrial and cell proliferation
Mitochondria, though mainly considered as specific sites of
regulation of the energy metabolism, are certainly multi-
functional [1]. Like the nuclear genome, mitochondria have to
replicate their DNA prior to cell division. However, the
mechanisms that allow the synchronization of cell proliferation
with mitochondrial genome replication are still obscure.
Mammalian mitochondrial DNA is a high copy-number,
maternally inherited genome that codes for a small number of
essential proteins involved in oxidative phosphorylation.
Mitochondrial DNA (mtDNA) accumulates somatic mutations
during aging, cancer progression and diabetes [2]. In the past⁎ Corresponding author.
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doi:10.1016/j.bbabio.2006.05.029decade, it has been demonstrated that a number of protein
factors encoded by nuclear genes are involved in the biogenesis
of mitochondria and the maintenance of mtDNA copy number
[3]. However, it remains unclear how the copy number of
mtDNA and the abundance of mitochondria are regulated under
different physiological and developmental conditions. Although
major advances in our understanding of the molecular bases of
replication, transcription and maintenance of mtDNA have been
made [4,5], information about how the genetic material is
organized and distributed in mammalian mitochondria and how
mtDNA molecules segregate before and during mitosis, thus
determining the genetic identity of daughter cells, is very
limited. Inherited or acquired mtDNA heteroplasmy appears
critical not only in the case of mitochondrial diseases, but in an
increasing number of age-related diseases, such as diabetes and
cancer [1,6]. MtDNA copy number is tightly regulated in a cell-
and tissue-specific manner by unknown mechanisms, and it is
not clear if and how mtDNA replication is linked to the cell
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correlation between mitochondrial biogenesis and function with
specific stages of the cell cycle [9–12]. In particular, it has been
demonstrated that, in some cell lines, growth factor stimulation
induces nuclear and mitochondrial replication.
1.2. Growth factors signaling and cellular proliferation
Growth factors, both cytokines and hormones, transduce
their effect inside the cell through a cascade of events that
mainly consist in protein complex association and post-
translational modifications. A key step of these signal
transduction events is the activation of p21Ras proteins, a
family of plasma membrane-associated GTP-binding protein
encoded by three mammalian genes: K-, N- and H-Ras. Ras
proteins are activated by diverse extra-cellular signals,
including integrins and growth factors, that bind to their
specific receptors and activate intracellular tyrosine-kinases.
The Ras pathway is among the most frequently altered in
tumors. Ras genes are themselves the most frequently mutated
oncogenes in spontaneously occurring human cancers (up to
30%) [13].
Fine regulators of Ras activation are the Shc proteins. The
Shc proteins were initially recognized as ‘adaptor’ proteins that
specifically bind to phosphorylated tyrosine residues on the
cytoplasmic motif of growth factor receptors. There are three
Shc proteins in mammals, the 46 kDa Shc (p46Shc), the 52 kDa
Shc (p52Shc), and the 66 kDa Shc (p52Shc). Upon growth factor
stimulation, p52Shc/p46Shc proteins are rapidly and efficiently
tyrosine-phosphorylated by all tyrosine kinases (TKs) tested
and recruit the Grb2–Sos complex on the plasma membrane
[14]. The hypothesis that Shc proteins are involved in the
regulation of Ras is supported by the findings that over-
expression of p52Shc/p46Shc increases Ras signaling and
proliferation upon stimulation with EGF, GM-CSF and PDGF
[15]. Indeed, evidences for divergent regulation of p66Shc and
p52Shc/p46Shc emerged from studies demonstrating that p66Shc,
like p52Shc/p46Shc, is a target of TK receptors (EGFR, INSR,
PDGFR) [15,16] and binds the Grb2/Sos complex, but it exerts
a negative effect on the Ras-MAPK-Fos pathway upon EGF
[17] or cytokines stimulations of fibroblasts or lymphocytes,
respectively [18]. Recently, p66Shc has been shown to exert an
inhibitory effect on the Erk pathway [19].
P66Shc localizes partially within the inter-membrane space
of mitochondria where it oxidizes cytochrome c, thus
producing hydrogen peroxide [20]. Electrochemical experi-
ments demonstrated that the amino terminal portion of
p66Shc contains a redox center that mediates electron transfer
from reduced cytochrome c to molecular oxygen, producing
H2O2. We have demonstrated that the H2O2 formed by p66
Shc
may favor the swelling of mitochondria, which then triggers
the opening of the mitochondrial permeability transition pore
and increases intracellular oxidative stress [20]. Notably, the
deletion of p66Shc in mice reduces apoptosis and oxidative
stress and prolongs life span of about one third, suggesting
that p66Shc is a genetic determinant of aging in mammals
[20–26].2. Materials and methods
2.1. Mice, cells and reagents
In this study, we used 129SvEv WT and p66Shc−/− mice at different ages.
Whole kidneys, liver and skin were dissected and immediately frozen for DNA
preparation.
Mouse NIH3T3 fibroblasts were grown in Dulbecco's modified Eagle
medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Mouse
embryonic fibroblasts (MEFs) and mouse adult skin fibroblasts (MAFs) were
prepared according to standard procedures and grown in DMEM 5% (v/v) FBS.
Media were supplemented with 1% penicillin-streptomycin. Cells were grown at
37 °C in a humidified atmosphere of 5% CO2. Brown adipocytes (ADPC) were
generated from newborn WT and p66Shc−/− mice according to standard
procedures and differentiation of these cells was induced with 20 nM insulin.
2.2. Cellular treatments
Centrifugal elutriation was performed in a Beckman JE 5.0 centrifuge and a
JE-5S rotor equipped with the standard separation chamber. Logarithmically
growing NIH/3T3 cells were introduced into the separation chamber. Cells were
elutriated at 4 °C in PBS. Elutriation was executed at a constant rotor speed of
2800 rpm. The fractionation of cells into various cell cycle subpopulations was
accomplished by increasing the pump speed stepwise. To test the cell cycle
distribution of cells within each fraction, an aliquot of cells was fixed with
ethanol, stained with propidium iodide and analyzed by a Becton-Dickinson
FACScan flow cytometer.
Mutated Ras, p66Shc WT and p66Shc mutant proteins were expressed in
MEFs using the pBABE-puro retroviral vector. Retroviral vector DNAs were
transfected into the Phoenix packaging cell lines and after 48 h supernatants
were used to infect target cells, which were then selected with 1 μg/ml
puromycin. Protein expression was analyzed by PAGE-SDS followed by
Western Blotting using anti-Ras or anti-Shc (Transduction Lab.) antibodies.
2.3. DNA preparation
Total genomic DNA was isolated with the QIAamp kit (Qiagen). MtDNA
content was determined in cells and tissues utilizing a quantitative real-time PCR
(QPCR) by the TaqMan method (ABI PRISM7700 Sequence Detection
System); specific primers were used to amplify a fragment of the mitochondrial
D-loop region:(MDF) 5′-AAT CTA CCATCC TCC GTG AAA CC and (MDR)
5′-TCA GTT TAG CTA CCC CCA AGT TTA A, probe 5′-FAM-
CGCCCACCAATGCCCCTCTTC-TAMRA or a fragment of nuclear genomic
telomerase gene region TERTF, 5′-CTA GCT CAT GTG TCA AGA CCC TCT
T and TERTR 5′-GCC AGC ACG TTT CTC TCG TT, probe 5′VIC-TCC TTA
CCA GGT GTC ATC CCT GAA AGA GC-TAMRA. PCR reactions were
performed according to standard conditions for TaqMan (Applied Biosystems):
50 °C for 2′; 95 °C for 10′; 40 cycles at 95 °C 15″, 60 °C 1′. PCR assays were
performed in triplicate for each DNA sample. The expression of mtDNA copy
number relative to nuclear DNA was determined using the 2−ΔCT method.3. Results
To investigate mtDNA biogenesis and nuclear DNA
replication we took advantage of synchronized cell populations.
In a first set of experiments we analyzed mtDNA copy number
in cell fractions of NIH3T3 fibroblasts obtained by elutriation.
The cell cycle profile of each fraction is shown in Fig. 1A. Cell
cycle distribution of the various cell fractions revealed a good
separation between G0/G1, S and G2/M (Fig. 1B). The mtDNA
content of various cell fractions was measured by QPCR, using
oligonucleotides primers specific for a fragment of the
mitochondrial D-loop region, and normalized with the content
of nuclear DNA. Results showed that mtDNA copy number was
Fig. 1. (A–C) MtDNA copy number in various cell cycle fractions of NIH3T3 fibroblasts. Cell fractions, enriched at specific phases of the cell cycle, were
obtained by elutriation. The FACS profile of each fraction is shown in panel A, their cell cycle distribution is shown in panel B. MtDNA content was measured by
real-time PCR and normalized with nuclear DNA. The results are expressed as a ratio relative to the value of fraction 1 (C). (D–F) Mt DNA replication afte
growth factor stimulation of NIH-3T3 fibroblasts NIH3T3 cells were G0–G1 synchronized by serum starvation and then induced to re-enter the cell cycle by the
addition of serum. FACS profiles and cell cycle distribution at each time point are shown in panels D and E respectively. MtDNA copy number, normalized with
nuclear DNA, is shown in panel F (the results are expressed as a ratio relative to the serum-starved fraction).
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Fig. 2. Ras controls of mtDNA copy number. Activated Ras (RasV12) was
expressed by retroviral infection in NIH3T3 cells and in MEFs, as indicated, and
the mtDNA content was measured by QPCR and normalized with nuclear DNA.
Results are expressed as a ratio relative to the value of the pBabe retroviral
control infection (A). Results from WB analysis of the expression levels of Ras
(B) and of growth properties (C) in the infected cells are reported.
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that it is regulated during the cell cycle. To obtain an
independent confirmation of this hypothesis, we then analyzed
mtDNA copy number during the re-entry into the S-phase of
G0/G1-synchronized cells. To this end, NIH3T3 cells were
serum-starved, to induce their exit of the cell cycle, and then
treated with serum, to allow their synchronous re-enter (see Fig.
1D for representative FACS profiles and Fig. 1E for their cell
cycle distribution). Notably, analysis of the mtDNA copy
number revealed a marked increase during late G0/G1 and early
S phase, just before the beginning of nuclear DNA replication
(Pre-S phase) (compare Fig. 1E and 1F). It appears, therefore,
that mtDNA is replicated during a specific phase of the cell
cycle (the pre-S phase) and that this process is regulated by
mitogenic growth factors.
Since Ras is critical for the cell-cycle control mediated by
growth factors and for growth arrest in non-transformed, check
point competent cells [27] we then investigated the role of Ras
in mitochondrial biogenesis. To this end, we expressed an
oncogenic mutant of Ras (rasV12 [28,29]) into NIH3T3
fibroblasts and primary mouse embryonic fibroblasts (MEFs).
Measurement of mtDNA copy number revealed that expression
of activated Ras is able to increase mtDNA content only in
NIH3T3 fibroblasts, while it has no effect, or a slight inhibitory
effect, in primary fibroblasts (Fig. 2A–B). The biological
consequences of mutated Ras expression in immortalized
(NIH3T3) and primary (MEFs) fibroblasts are profoundly
different, since it induces hyper-proliferation and transforma-
tion of NIH3T3 cells and replicative senescence of MEFs, (Fig.
2C) the latter being the consequence of the activation of a p53-
dependent checkpoint [27]. It appears, therefore, that Ras is not
sufficient, per se, to trigger mtDNA replication; instead,
mtDNA replication appears to be the consequence of the Ras-
induced activation of a signaling pathway which then leads to
nuclear DNA replication.
A growing body of evidence suggests that reactive oxygen
species (ROS) regulate a number of diverse intracellular
pathways including those triggered by Ras [28]. Considering
that p66Shc is implicated in the regulation of Ras and
mitochondrial production of ROS, we investigated the role
of p66Shc in mtDNA replication. We first analyzed the content
of mtDNA in MEFs, MAFs (Mouse Adult Fibroblasts) and
ADPC (Adipocytes) derived from WT or p66Shc-null
(p66Shc−/−) mice. Notably, in all cases, a marked decrease
of mtDNA content was observed in the absence of p66Shc
expression (Fig. 3A). Consistently, the over-expression of
p66Shc into WT or p66Shc−/− MEFs induced a marked
increase (of about 2-folds) of mtDNA content (Fig. 3B).
Together, these findings indicate that levels of p66Shc
expression regulate mtDNA replication.
To preliminarily investigate the molecular mechanisms
underlying the effect of p66Shc expression on mtDNA
replication, we analyzed the ability of relevant p66Shc mutants
to increase the mtDNA content into p66Shc−/− MEFs. To this
end, we used phosphorylation-defective p66Shc Ser36Ala
(p66a) and redox defective p66Shc Glu132Gln,Glu133Gln
(p66qq) p66Shc mutants. Both mutants are unable to execute thepro-apoptotic programme of p66Shc, by interfering with
different properties of p66Shc: the ability to undergo oxidative
stress-induced phosphorylation at the serine 36 residue, and the
ability to generate mitochondrial ROS, respectively [20,21].
Strikingly, both mutants were able to increase mtDNA content,
upon retroviral-mediated gene transfer into p66Shc−/− MEFs
(Fig. 3C), thus indicating that this property of p66Shc relies on
novel molecular mechanisms, regardless from their ability to
induce ROS production (Fig. 3 D–E).
MtDNA content has been shown to increase with age and in
several age-associated diseases [7,30]. Thus, we analyzed
mtDNA content in different tissues from WT and p66Shc−/−
Fig. 4. P66Shc controls age-dependent accumulation ofmtDNA.MtDNAcontentwas
measured by QPCR in the liver, skin and kidney from 2 to 12 months old p66Shc−/−
mice and comparedwithmatched controls. Results are normalizedwith nuclearDNA
and expressed as a ratio relative to the value of WT samples at 2 months.
Fig. 3. P66Shc increasesmtDNAcopy number.MtDNA copy numberwasmeasured byQPCRand normalizedwith nuclear DNA inMEFs,MAFs andADPC fromWTand
p66Shc−/− mice. Results are expressed as a ratio of p66Shc−/− versus WT samples (A). p66Shc was reintroduced in WT and p66Shc−/−MEFs by retroviral infection and
mtDNA content wasmeasured byQPCR at different days from the end of puromycin selection (day 0 corresponds to the first day after selection). Results are expressed as a
ratio relative to the pBabe control infection of WTcells (B). P66Shc WT protein, p66a and p66qqmutants were expressed by retroviral infection into p66Shc−/−MEFs, as
indicated, andmtDNA content wasmeasured byQPCR.Results are expressed as a ratio relative to the value of the pBabe control (C); p66 Shc−/−MEFs expressing different
p66 Shc mutants were stained with DCFDA and analyzed by FACS (D); levels of p66 Shc expression were analyzed byWB using anti-Shc and anti-βtubulin antibodies (E).
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significantly higher in the liver, skin and kidney of WTold mice
(as observed comparing 12 versus 2 months old animals). In old
p66Shc−/−mice, instead, mtDNA content did not increase (skin)
or increased modestly (liver and kidney) (Fig. 4). It appears,
therefore, that the age-dependent increase of tissue mtDNA is
lost or significantly reduced in p66Shc−/− mice.
4. Discussion
Though recent progress has been made in mitochondrial
genetics, several fundamental questions remain unanswered.
Mitochondrial replication must be tightly regulated when cells
divide, when they differentiate, increase in size or respond to
changes in their environment. However, we still do not know
how the ratio of mitochondrial to nuclear DNA is maintained,
how the number of mitochondria is adjusted to meet various
cellular needs and how mtDNA contributes to aging and
various age-associated diseases, including cancer.
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by an increase in respiratory activity, usually accompanied by
an increase in mitochondrial mass. An increase in mitochon-
drial proliferation presents a unique challenge to cells, because
mitochondrial biogenesis requires protein products that are
encoded by both nuclear and mitochondrial genomes,
suggesting that a variety of intracellular and extra-cellular
signals have to be integrated. We measured mtDNA copy
number during cell cycle progression and, consistent with
previous reports [9–11], we found that mtDNA is mostly
replicated in the pre-S phase, suggesting a tight correlation
between mitochondrial biogenesis and specific stages of the
cell cycle. We then demonstrated that serum-induced cell cycle
re-entry correlates with increased mtDNA copy number,
suggesting that growth factors are part of the molecular
mechanisms which couple mitochondrial proliferation to
environmental signals. Ras proteins function as a point of
convergence for different signaling pathways and have been
implicated in both aging and cancer development. Notably, we
observed that activated Ras (RasV12) is able to regulate
mtDNA replication. This effect, however, only occurs in cells
where Ras induce a full hyper-proliferative response, suggest-
ing that Ras-induced mtDNA replication is tightly linked to
the ability of Ras to also induce nuclear DNA replication. It
appears, therefore, that Ras functions as a molecular switch in
cell cycle regulation by coupling cell surface receptors to the
nucleus, cytoskeleton and also mitochondria. The molecular
determinants of this novel function of Ras are unknown and
may involve the fraction of Ras proteins that localizes within
mitochondria and its ability to stimulate intracellular ROS
production [31,32].
Our data suggest that p66Shc is also part of the signaling
pathway that regulates mtDNA replication, though its
mechanistic relation with Ras remains to be determined. We
found that p66Shc expression stimulates mtDNA copy number
both in vitro and in vivo. Notably, this effect of p66Shc likely
reflects its involvement in other signaling pathways, with
respect to those already known. In fact, p66Shc mutants that
are defective for the ability of the WT protein to induce ROS
production and apoptosis are still able to stimulate mtDNA
replication.Acknowledgments
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